
acromion GmbH is a privately held full-service CRO headquartered in Germany. Acromion supports biotechnology, pharmaceutical, medical device and diagnostics companies across the full scope of clinical trial execution. With a broad service portfolio from study development and clinical monitoring through biostatistics, data management and medical writing to quality management and clinical operations, acromion accompanies complex study projects across the entire lifecycle.
As a full-service CRO, acromion relies not only on delivering studies with operational excellence, but also managing them in an economically transparent and reliable way. Specialized software solutions such as Trialytix play a central role in securing efficiency, scalability and profitability in the dynamic day-to-day of clinical research.
As a CRO, acromion is faced every day with the task of precisely budgeting and efficiently managing complex and dynamic study projects without losing the overview of costs, revenues and resources.
In the past, budgeting, project management and financial administration were largely handled in Excel spreadsheets. With a growing number of studies running in parallel and their constantly changing conditions, this approach increasingly reached its limits and brought several recurring challenges:
With Trialytix, acromion implemented a central software solution for budgeting, forecasting and financial controlling of clinical trial projects. The platform digitizes and automates central processes of financial and operational study administration and replaces Excel structures with an integrated system.
Key benefits of the solution:
Thanks to the intuitive user interface, even complex processes such as budget tracking and cost control can be mapped efficiently and clearly. Teams and departments receive a shared, reliable data basis and can react more quickly to changes. The real-time data and precise reporting tools support acromion in making study projects more profitable and more efficient.

With Trialytix, acromion is fundamentally transforming the financial and operational management of its clinical studies. The platform enables transparent control of budgets, forecasts and performance and at the same time significantly reduces the administrative effort.
Real-time data, automated alerts and integrated budget functions enable decisions based on a data foundation that was previously not available in this form. This allows acromion to focus more strongly on its core task: the successful, high-quality conduct of clinical studies.
Trialytix supports Acromion as a reliable partner and continuously evolve the platform further – tailored precisely to the requirements of modern CROs and the rising complexity of clinical trial projects.